Proteoglycans and glycosaminoglycans (PGAGs) are essential macromolecules composed of proteins and glycosaminoglycans (GAGs), playing crucial roles in a variety of biological processes. These molecules are involved in cell signaling, tissue repair, regulation of cell growth, and maintaining the structural integrity of tissues. The biosynthesis of PGAGs involves a series of complex enzymatic reactions, and understanding the genes involved in this process can offer valuable insights into several diseases, including cancers, autoimmune disorders, and developmental diseases.
AnyGenes qPCR arrays are an invaluable tool for studying the genes involved in PGAG biosynthesis. Our high-throughput qPCR arrays provide precise gene expression profiling, allowing researchers to identify key enzymes and regulatory genes, investigate disease mechanisms, and monitor gene expression in various tissues.
By leveraging AnyGenes qPCR solutions, researchers can enhance their studies on PGAG biosynthesis, leading to more informed insights and potential therapeutic breakthroughs.
The biosynthetic pathways of heparan sulfate and chondroitin sulfate/dermatan sulfate. HS, heparan sulfate; CS, chondroitin sulfate; DS, dermatan sulfate; 2S, 2-O-sulfation; 6S, 6-O-sulfation; 3S, 3-O-sulfation; 4S, 4-O-sulfation; NS, N-sulfated glucosamine. XylT1/2, xylosyltransferase 1/2; FAM20B, family with sequence similarity member 20-B; PXYLP1, 2-phosphoxylose phosphatase; GalT-I, galactosyltransferase-I; GalT-II, galactosyltransferase-II; GlcAT-Ⅰ, glucuronyltransferase-Ⅰ;
EXT1, exostosin glycosyltransferase 1; EXT2, exostosin glycosyltransferase 2; EXTL1, exostosin like glycosyltransferase 1; EXTL2, exostosin like glycosyltransferase 2; EXTL3, exostosin like glycosyltransferase 3; NDST1, N-sulfotransferase; NDST2, N-sulfotransferase 2; NDST3, N-sulfotransferase 3; NDST4, N-sulfotransferase 4; HS6ST1, heparan sulfate 6-O-sulfotransferase 1; HS6ST2, heparan sulfate 6-O-sulfotransferase 2; HS6ST3, heparan sulfate 6-O-sulfotransferase 3; HS3ST1, heparan sulfate 3-O-sulfotransferase 1; HS3ST2, heparan sulfate 3-O-sulfotransferase 2; HS3ST3a, heparan sulfate 3-O-sulfotransferase 3a; HS3ST3b, heparan sulfate 3-O-sulfotransferase 3b; HS3ST4, heparan sulfate 3-O-sulfotransferase 4; HS3ST5, heparan sulfate 3-O-sulfotransferase 5; HS3ST6, heparan sulfate 3-O-sulfotransferase 6;
GLCE, C-5 epimerase; HS2ST, heparan sulfate 2-O-sulfotransferase; GalNAcT- I, GalNAc transferase-I; GalNAcT- IIs, GalNAc transferase-II; GlcAT- II,β1,3-glucuronyltransferase- II; C4ST, chondroitin 4-O-sulfotransferase; C6ST,; GalNAc4S-6ST,; UST, uronyl 2-O-sulfotransferase; DSE1, DS epimerase1; DSE2, DS epimerase2; D4ST, dermatan 4-O-sulfotransferase; GalNAc4S-6ST, GalNAc 4-sulfate 6-O-sulfotransferase. Monosaccharides in this figure are represented in accordance with the symbol nomenclature for glycans (SNFG) (Varki et al., 2015).
Proteoglycans (PGs) are essential components of the extracellular matrix, composed of a core protein covalently linked to glycosaminoglycans (GAGs). GAGs are long, unbranched polysaccharides that play crucial roles in various biological processes, including cell signaling, adhesion, and the structural integrity of tissues.
Each GAG type has distinct biosynthetic pathways and functions, significantly influenced by the specific genes involved in their synthesis.
The biosynthesis of GAGs involves several key steps and enzymes:
More than 50 genes are implicated in GAG biosynthesis, including:
Defects in PGAG biosynthesis can lead to a range of disorders. Genetic mutations affecting the enzymes responsible for GAG synthesis have been linked to conditions such as: Skeletal Dysplasias, Cognitive Impairments, Cancer, Osteoarthritis, Neurological Disorders.
Research has shown that abnormalities in PGAGs can affect cell proliferation, migration, and adhesion, contributing to disease progression. Understanding PGAG biosynthesis opens avenues for therapeutic interventions. Targeting specific enzymes involved in GAG synthesis may provide strategies for treating related disorders. For instance, enhancing or inhibiting GAG production could be explored as a therapeutic approach in cancer treatment or regenerative medicine.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
contact@anygenes.com
to get started on your project.